Health Condition 1: N289- Disorder of kidney and ureter, unspecified
Conditions
Interventions
Intervention1: Group 1 Intranasal Midazolam
: Intranasal Midazolam 0.25mg/kg
will be given with as nasal instillation, half dose in each nostril. Each instillation will be given at a gap of 30 second
Sponsors
Dr Aarti Agarwal
Eligibility
Inclusion criteria
Inclusion criteria: • Children between 2-12 years of age • Weight • ASA I and II • Scheduled for elective surgery
Exclusion criteria
Exclusion criteria: 1. Patientâ??s parent consent refusal 2. Patients with known allergy to any medications, running nose, upper respiratory tract infections, mental retardation, or neurobehavioral problems. 3. Emergency surgery 4. Patient belonging to ASA 3 or 4 group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| separation anxiety via parental separation anxiety score Grade 1: Easy separation Grade 2: Whimpers, but is easily reassured, not clinging Grade 3: Cries and cannot be easily reassured, but not clinging Grade 4: Crying and clinging to parents Timepoint: 20 minutes after nasal drug instillation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Facemask acceptance 1.With crying 2.Without crying Timepoint: 20 minutes after nasal drug instillation.;IV Cannulation 1: Poor (Terrified and Crying) 2: Fair (Fear of needle, Not reassured) 3: Good (slight fear of needle, easily reassured) 4: Excellent (unafraid, accepts IV cannulation readily) Timepoint: 20 minutes after nasal drug instillation.;Salivation 1. Requiring suctioning 2. Not requiring suctioning Timepoint: 20 minutes after nasal drug instillation.;Sedation score 1: Agitated 2: Awake 3: Drowsy 4: Asleep Timepoint: 20 minutes after nasal drug instillation. | — |
Countries
India
Contacts
Public ContactDr Neeraj Pal Singh
SGPGIMS, LUCKNOW
Outcome results
None listed